Avenue Supermarts 19% Revenue Jump Signals D-Mart Recovery Phase

D-Mart Breaks Revenue Stagnation Cycle Avenue Supermarts (NSE: DMART) delivered its strongest quarterly performance in eight quarters, posting 19% YoY revenue growth in Q4FY24 that caught Street estimates off-guard. The ₹13,714 crore quarterly revenue marked a decisive break from the retailer's prolonged expansion slowdown that had pressured margins and store productivity metrics since early 2022. The numbers signal potential inflection for India's largest supermarket chain, which had been grappling with post-pandemic normalization challenges and aggressive expansion costs. Same-store sales growth (SSSG) accelerated to 12.8% from sub-10% levels in previous quarters, while new store additions picked up pace with 24 outlets launched versus 18-20 in recent quarters. Retail Sector Divergence Widens D-Mart's recovery contrasts sharply with mixed signals across Indian retail. While NSE: TRENT continues its premium retail momentum with 40%+ growth, value retailers like NSE: VMART struggle with rural demand headwinds. Avenue Supermarts' performance suggests the organized grocery segment may be hitting a sweet spot between premium fatigue and rural stress. The company's inventory turnover improved to 42 days from 47 days YoY, indicating better demand forecasting and supply chain optimization. Gross margins expanded 80bps to 14.2%, reversing five quarters of compression. This operational leverage validates management's strategy of prioritizing profitability over pure expansion velocity—a shift that initially spooked growth-focused investors but now appears prescient. Brokerages are reassessing coverage with Kotak upgrading to BUY from HOLD, citing "sustainable recovery in core metrics." The stock trades at 65x FY25E earnings versus historical averages of 75-80x, suggesting potential re-rating catalysts remain if momentum sustains. Portfolio Implications for Retail Exposure For institutional portfolios, D-Mart's recovery validates selective retail exposure over broad-b...